| HOME >> MEDICINE >> TECHNOLOGY |
Table 30: Chronic Heart Failure Therapeutics Market - Preclinical Pipeline, 2011 47
Table 31: Chronic Heart Failure Therapeutics Market - Discovery Pipeline, 2011 47
Table 32: Chronic Heart Failure - Most Promising Drugs Under Clinical Development, 2011 50
Table 33: Chronic Heart Failure Therapeutics Market, Clinical Trials by Region, 2011 54
Table 34: Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Phase of Development, 2011 55
Table 35: Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Trial Status, 2011 56
Table 36: Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Overall Sponsors, 2011 57
Table 37: Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Prominent Sponsors, 2011 58
Table 38: Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Lead Sponsors, 2011 59
Table 39: Pipeline Molecules 2011 64
Table 40: Pipeline Molecules 2011 66
Table 41: Pipeline Molecules 2011 66
Table 42: Pipeline Products 2011 68
Table 43: Pipeline Products 2011 69
Table 44: Pipeline Products 2011 69
Table 45: Pipeline Products 2011 71
Table 46: Product Pipeline 2011 72
Table 47: Pipeline Products 2011 72
Table 48: Licensing and Partnership Deals 73
List of Figures 1.2 List of FiguresFigure 1: Pathophysiology of Chronic Heart Failure 12
Figure 2: Treatment Algorithm for Acute Heart Failure with Systolic Dysfunction 19
Figure 3: Treatment Algorithm for Heart Failure 19
Figure 4: Chronic Heart Failure Therapeutics Market, Global, Revenue ($m), 2006-2011 21
Figure 5: Chronic Heart Failure Therapeutics Market, Global, Forecast ($m), 2011-2019 22
Figure 6: Chronic Heart Failure Therapeutics Market, The US, Revenue ($m), 2006-2011 23
Figure 7: Chronic Heart Failure Therapeutics Market, The US, Forecast ($m), 2011-201
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |